Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Regulated proteolysis of the polyprotein precursor by the NS2B-NS3 protease is required for the propagation of infectious virions. Unless the structural and functional parameters of NS2B-NS3 are precisely determined, an understanding of its functional role and the design of flaviviral inhibitors will be exceedingly difficult. Our objectives were to define the substrate recognition pattern of the NS2B-NS3 protease of West Nile and Dengue virises (WNV and DV respectively). To accomplish our goals, we used an efficient, 96-well plate format, method for the synthesis of 9-mer peptide substrates with the general P4-P3-P2-P1-P1'-P2'-P3'-P4'-Gly structure. The N-terminus and the constant C-terminal Gly of the peptides were tagged with a fluorescent tag and with a biotin tag respectively. The synthesis was followed by the proteolytic cleavage of the synthesized, tagged peptides. Because of the strict requirement for the presence of basic amino acid residues at the P1 and the P2 substrate positions, the analysis of approx. 300 peptide sequences was sufficient for an adequate representation of the cleavage preferences of the WNV and DV proteinases. Our results disclosed the strict substrate specificity of the WNV protease for which the (K/R)(K/R)R/GG amino acid motifs was optimal. The DV protease was less selective and it tolerated well the presence of a number of amino acid residue types at either the P1' or the P2' site, as long as the other position was occupied by a glycine residue. We believe that our data represent a valuable biochemical resource and a solid foundation to support the design of selective substrates and synthetic inhibitors of flaviviral proteinases.

[1]  A. Gamarnik,et al.  The active essential CFNS3d protein complex , 2006, The FEBS journal.

[2]  P. Prusis,et al.  Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides. , 2006, The Biochemical journal.

[3]  M. Lebl,et al.  A method for rapid protease substrate evaluation and optimization. , 2006, Combinatorial chemistry & high throughput screening.

[4]  Zheng Yin,et al.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus , 2006, Nature Structural &Molecular Biology.

[5]  M. Lebl,et al.  Alternative to piperidine in Fmoc solid-phase synthesis. , 2006, Journal of combinatorial chemistry.

[6]  Kevin D Raney,et al.  Structural and Biological Identification of Residues on the Surface of NS3 Helicase Required for Optimal Replication of the Hepatitis C Virus* , 2006, Journal of Biological Chemistry.

[7]  Jeffrey W. Smith,et al.  Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. , 2006, The Biochemical journal.

[8]  N. Seidah Unexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinases. , 2006, The Biochemical journal.

[9]  D. Beasley Recent advances in the molecular biology of west nile virus. , 2005, Current molecular medicine.

[10]  Jennifer L. Harris,et al.  Functional Profiling of Recombinant NS3 Proteases from All Four Serotypes of Dengue Virus Using Tetrapeptide and Octapeptide Substrate Libraries*[boxs] , 2005, Journal of Biological Chemistry.

[11]  K. Murthy,et al.  Modulation of the Nucleoside Triphosphatase/RNA Helicase and 5′-RNA Triphosphatase Activities of Dengue Virus Type 2 Nonstructural Protein 3 (NS3) by Interaction with NS5, the RNA-dependent RNA Polymerase* , 2005, Journal of Biological Chemistry.

[12]  K. Murthy,et al.  Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities. , 2005, The Journal of general virology.

[13]  Martin J. Stoermer,et al.  Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions* , 2005, Journal of Biological Chemistry.

[14]  P. Niyomrattanakit,et al.  Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation , 2004, Journal of Virology.

[15]  Martin J. Stoermer,et al.  Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease* , 2004, Journal of Biological Chemistry.

[16]  I. Lindberg,et al.  Inhibition of Furin by Polyarginine-containing Peptides , 2004, Journal of Biological Chemistry.

[17]  P. Malasit,et al.  Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue Viruses , 2004, Journal of Virology.

[18]  M. Diamond,et al.  Pathogenesis of flavivirus encephalitis , 2003, Advances in Virus Research.

[19]  Shao-Hung Wang,et al.  Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins. , 2003, Journal of virological methods.

[20]  N. Shafee,et al.  Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis. , 2003, The Journal of general virology.

[21]  R. Fischer,et al.  Extending the applicability of carboxyfluorescein in solid-phase synthesis. , 2003, Bioconjugate chemistry.

[22]  P. Niyomrattanakit,et al.  Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides. , 2003, Protein and peptide letters.

[23]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[24]  C. Samuel,et al.  Host genetic variability and West Nile virus susceptibility , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Katzenmeier,et al.  In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates. , 2002, Journal of biochemistry and molecular biology.

[26]  Martin J. Stoermer,et al.  Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors* , 2001, The Journal of Biological Chemistry.

[27]  C. Hayes West Nile Virus: Uganda, 1937, to New York City, 1999 , 2001, Annals of the New York Academy of Sciences.

[28]  Ding‐Shinn Chen,et al.  Structure-Based Mutational Analysis of the Hepatitis C Virus NS3 Helicase , 2001, Journal of Virology.

[29]  R. Yusof,et al.  Purified NS2B/NS3 Serine Protease of Dengue Virus Type 2 Exhibits Cofactor NS2B Dependence for Cleavage of Substrates with Dibasic Amino Acids in Vitro* , 2000, The Journal of Biological Chemistry.

[30]  M. Lebl New technique for high-throughput synthesis. , 1999, Bioorganic & medicinal chemistry letters.

[31]  D. Fairlie,et al.  Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. , 1999, The Journal of general virology.

[32]  M. Lobigs,et al.  Signal Peptidase Cleavage at the Flavivirus C-prM Junction: Dependence on the Viral NS2B-3 Protease for Efficient Processing Requires Determinants in C, the Signal Peptide, and prM , 1998, Journal of Virology.

[33]  R. Padmanabhan,et al.  Cotranslational Membrane Insertion of the Serine Proteinase Precursor NS2B-NS3(Pro) of Dengue Virus Type 2 Is Required for Efficient in Vitro Processing and Is Mediated through the Hydrophobic Regions of NS2B* , 1997, The Journal of Biological Chemistry.

[34]  F. Heinz,et al.  Proteolytic activation of tick-borne encephalitis virus by furin , 1997, Journal of virology.

[35]  R. Compans,et al.  Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components , 1997, Journal of virology.

[36]  C. Rice,et al.  Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics , 1994, Journal of virology.

[37]  R. Compans,et al.  Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study , 1994, Journal of virology.

[38]  C. Rice,et al.  Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication , 1993, Journal of virology.

[39]  R. Miller,et al.  Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity , 1993, Journal of virology.

[40]  C. Rice,et al.  Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. , 1993, Virology.

[41]  C. Lai,et al.  Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease , 1992, Journal of virology.

[42]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[43]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[44]  J. H. Strauss,et al.  In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3 , 1990, Journal of virology.

[45]  Michal Lebl,et al.  Search for optimal coupling reagent in multiple peptide synthesizer. , 2006, Biopolymers.

[46]  M. Lebl,et al.  Simple tools for resin distribution. , 2005, Journal of combinatorial chemistry.

[47]  M. Rossmann,et al.  A structural perspective of the flavivirus life cycle , 2005, Nature Reviews Microbiology.

[48]  Michal Lebl,et al.  High-throughput peptide synthesis. , 2005, Methods in molecular biology.

[49]  C. Mandl,et al.  Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. , 2003, The Journal of general virology.

[50]  B. Oh,et al.  Crystallization and preliminary X-ray crystallographic analysis of the helicase domain of hepatitis C virus NS3 protein. , 1998, Acta crystallographica. Section D, Biological crystallography.